3
Announcements
Trials
Browse
Landscape
Status
Completed
4
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Neoplasms
38
Breast Neoplasms
31
Lung Neoplasms
25
Colorectal Neoplasms
15
Prostatic Neoplasms
13
Pancreatic Neoplasms
11
Ovarian Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Head and Neck Neoplasms
9
Sarcoma
8
Colonic Neoplasms
8
Carcinoma, Hepatocellular
8
Uterine Cervical Neoplasms
7
Glioma
7
Esophageal Neoplasms
7
Melanoma
6
Lymphoma
6
Endometrial Neoplasms
6
Neoplastic Cells, Circulating
5
Multiple Myeloma
5
Brain Neoplasms
5
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm, Residual
4
Gastrointestinal Neoplasms
4
Carcinoma, Squamous Cell
4
Carcinoma, Renal Cell
4
Adenocarcinoma
4
Thrombosis
3
Rectal Neoplasms
3
Interventions
Cyclophosphamide
55
fludarabine
29
Methotrexate
25
blinatumomab
22
Dexamethasone
22
Cytarabine
21
Vincristine
20
venetoclax
18
fludarabine phosphate
15
Specimen Handling
15
Whole-Body Irradiation
13
Stem Cell Transplantation
11
Biopsy
11
Tacrolimus
10
Prednisone
10
Mycophenolic Acid
10
Mercaptopurine
10
Daunorubicin
10
Thiotepa
9
Rituximab
9
Melphalan
9
Immunotherapy, Adoptive
9
Doxorubicin
8
pegaspargase
7
Magnetic Resonance Spectroscopy
7
Inotuzumab Ozogamicin
7
Granulocyte Colony-Stimulating Factor
7
Cyclosporine
7
Calcium Dobesilate
7
ponatinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Blood Specimen Collection
×
Clear all
NCT06537726
2025-04-10
REDEFINE
University of Zurich
Recruiting
130 enrolled